Measurement of Arch Motion After Bunion Surgery

October 30, 2019 updated by: University of Minnesota

First Ray Kinematics Following Lapidus Bunion Surgery: A Fluoroscopic Gait Study

This study is an observational "change from baseline" outcome measures design. Data is collected for the sake of evaluating treatment (fusion surgery) performed as standard medical care, but the investigator does not assign specific interventions to any participants in this study.

Study Overview

Status

Terminated

Detailed Description

Device/fluoroscopy measurements of arch motion and questionnaire data will be acquired on 10 women undergoing surgery for bunion, and 10 controls. Surgery will implant hardware to fuse (stabilize) the arch. Methods will evaluate the patient's problems associated with bunion and satisfaction with surgery, and assess the effectiveness of surgery in reducing motion of the arch. The hypotheses are that patients treated with surgery will demonstrate improvement in function, and that surgery will reduce motion of the arch postoperatively (posttest measures acquired 6 months after surgery), and in comparison to measures taken on a control group.

The data collected will come from a comprehensive examination. Methods will include the measurement of arch motion made by an examiner using a device and a fluoroscopic gait examination procedure, and completion of two medical questionnaires. The fluoroscopic acquisition of the digital images will be analyzed across the specified time dimensions of the gait cycle.

Device and fluoroscopy of measures of arch motion will be made at 2 time points on patients enrolled in this study: presurgery (baseline) and 6 months postsurgery. The questionnaire measurements of self-reported pain and function will be made at 4 time points: presurgery (baseline) and again at 3 months, 6 months, and 12 months postsurgery. Outcome measurements will be collected on control subjects at one time point only, on the day of their enrollment into the study.

Prospective studies have not characterized outcomes in patients receiving this type surgical fusion as part of the corrective treatment for bunion. Results have potential to improve surgical treatment outcomes and, improve upon the current methods of fluoroscopic motion analysis.

Study Type

Observational

Enrollment (Actual)

2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55455
        • University of Minnesota

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Patients having bunion will be recruited from the surgical practice of the Co-I. The surgeon will screen the patients, and invite those to participate identified as having an unstable arch as a complication of bunion deformity.

Controls will be recruited from the community, group matched for age. Controls must have normal foot posture and display no evidence of an unstable arch.

Description

Inclusion Criteria:

  • Age 18 or older.
  • Women.
  • Able to comprehend the risks associated with the study.
  • Able to complete the paperwork required for enrollment.
  • Able to walk without assistance of another individual.

Exclusion Criteria:

  • Pregnancy
  • History of great toe, forefoot or arch surgery, or severe traumatic injury.
  • Reduced ankle or great toe motion that impairs the ability to walk.
  • Observed evidence of foot deformity other than bunion.
  • Insensate to skin sensation testing which could indicate neuropathy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Bunion
Patients being treated for foot bunion with surgery.
Controls (normal foot)
Participants in this group will not undergo surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fluoroscopy Examination of the Foot.
Time Frame: Change in Outcome Measurement [presurgery (baseline) and again 6 months postsurgery]

Fluoroscopic examination will image the foot during the roll-over phase of the gait. The participant will step in slow motion in front of the fluoroscopic x-ray beam to record the change in the position of the arch at specified gait-event time dimensions. Image acquisition will be at 25 frames per second lasting no longer than 2 seconds. All participants will wear leaded clothing in accordance with a protocol approved by the Univ of Minnesota Department of Health and Safety, Radiation Protection Division.

Fluoroscopy "change in outcome measures" of arch motion will be made at 2 time points on all patients who participate: presurgery (baseline) and again 6 months postsurgery.

Fluoroscopy measures will be acquired on control subjects at one time point only, on the day of their enrollment into the study.

Change in Outcome Measurement [presurgery (baseline) and again 6 months postsurgery]

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Device Measurement of Arch Motion.
Time Frame: Change in Outcome Measurement. [presurgery (baseline) and again 6 months postsurgery]

Device measurement of arch motion will be acquired using the device built for this one purpose. Device measurements will be made on the both feet.

Device "change in outcome measurement" of arch motion will be made a 2 time points on all patients: presurgery (baseline) and again 6 months postsurgery.

Device measures of arch motion will be acquired on control subjects at one time point only, on the day their enrollment into the study.

Change in Outcome Measurement. [presurgery (baseline) and again 6 months postsurgery]

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Medical Questionnaires.
Time Frame: Change in Outcome Measurements. [presurgery (baseline) and again at 3 months, 6 months, and 12 months postsurgery]

The Foot Function Index medical questionnaire has separate subscales that assess health in the multiple dimensions of pain, activity limitation, disability and stiffness. Level of pain will also be recorded on the standard 1-10 medical pain scale.

The "change in outcome measures" of the self-reported pain and function will be made at 4 time points on all patients who participate: presurgery (baseline) and again at 3 months, 6 months, and 12 months postsurgery.

Questionnaire measures will be acquired on control subjects at one time point only, on the day of their enrollment into the study.

Change in Outcome Measurements. [presurgery (baseline) and again at 3 months, 6 months, and 12 months postsurgery]

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ward M Glasoe, PhD, PT, University of Minnesota

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2014

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

February 18, 2014

First Submitted That Met QC Criteria

February 27, 2014

First Posted (Estimate)

February 28, 2014

Study Record Updates

Last Update Posted (Actual)

November 1, 2019

Last Update Submitted That Met QC Criteria

October 30, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 1401M47629

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hallux Valgus

Subscribe